Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Prevention of Morbidity in Sickle Cell Disease Phase II (Improvement of Cognition in children with Sickle Cell Disease with Auto-adjusting Continuous Positive Airways Pressure: Phase II) (POMS 2b paediatric cohort)

April E Slee, Jamie M Kawadler, PhD, Melanie Koelbel, MSc, Hanne Stotesbury, MSc, David C Rees, MD, Maria Pelidis, MD, Jo Howard, MBBCh, Swee Lay Thein, DSc,FRCP,FRCPath,MBBS,MRCPath,MRCP, Simon Skene, PhD, Sahota Sati, BSc, Carol Nwosu, BSc, Maureen Gwam, BSc, Dawn Saunders, MD, Johanna C Gavlak, PhD, Gupta Atul, MD, Simrat Sarkaria, Christina Liossi, PhD, Fenella J Kirkham, MD, Baba Inusa, MD MRCP

Blood (2017) 130 (Supplement 1): 3556.

https://doi.org/10.1182/blood.V130.Suppl_1.3556.3556

Published: 2017

Journal Articles

Prevention of Morbidity in Sickle Cell Disease Phase II (Improvement of Pain and Quality of Life in Children with Sickle Cell Disease with Auto-adjusting Continuous Positive Airways Pressure: Phase II) (POMS 2b pediatric cohort)

Baba Inusa, MD MRCP, Jo Howard, MBBCh, Subarna Chakravorty, MBBS, PhD FRCPath, MRCP, Maria Pelidis, MD, Swee Lay Thein, DSc,FRCP,FRCPath,MBBS,MRCPath,MRCP, Fenella J Kirkham, MD

Blood (2017) 130 (Supplement 1): 3537.

https://doi.org/10.1182/blood.V130.Suppl_1.3537.3537

Published: 2017

Journal Articles

Overnight Respiratory Support for Prevention of Morbidity in Sickle Cell Disease (POMS 2a) - Parent and Child Preferences

Baba Inusa, MD, SallyAnn Wakeford, Fenella Kirkham, MD

Blood (2015) 126 (23): 4457.

https://doi.org/10.1182/blood.V126.23.4457.4457

Published: 2015

Journal Articles

Cerebral Blood Flow-Velocity Is Associated with Increased Leukocyte Count and Systolic Blood Pressure in HbSS but Not HbSC

Raffaela Colombatti, MD PhD, Soundrie Padayachee, PhD, Corrina Macmahon, MD FRCPath, Sukhleen Momi, BSC, Claire Jane Hemmaway, MD, Maddalena Casale, Baba Inusa, MD

Blood (2015) 126 (23): 989.

https://doi.org/10.1182/blood.V126.23.989.989

Published: 2015

Journal Articles

Prevention of Morbidity in Sickle Cell Disease (POMS 2): A Pilot Study of Nocturnal Respiratory Support Shows That Auto-Adjusting Positive Airways Pressure Is Safe and Is Preferred to Oxygen Therapy

Jo Howard, MD, Baba Inusa, MD, Christina Liossi, David C. Rees, FRCP, FRCPath, MA, MBBS, Swee Lay Thein, MD DSc, Edith Cheng, Sati Sahota, Nicholas Hart, MD, Patrick Murphy, MD, Johanna Gavlak, Maria Chorozoglou, Eufemia Jacob, PhD RN, Carol Nwosu, Maureen Gwam, SallyAnn Wakeford, Fenella Kirkham, MD

Blood (2015) 126 (23): 993.

https://doi.org/10.1182/blood.V126.23.993.993

Published: 2015

Journal Articles

A 2-Dose Schedule of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Given to Children with Sickle Cell Disease Previously Immunized with 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23): Results of a Phase 3 Study

Mariane De Montalembert, MD, Miguel R. Abboud, MD, Anne Fiquet, MD, Adlette Inati, MD, Jeffrey D. Lebensburger, DO, Normeen Kaddah, MD, Antonio Piga, MD, Baba Inusa, MD, Qin Jiang, MS, Lisa Pereira, BSc, Emilio A. Emini, PhD, William C. Gruber, MD, Alejandra Gurtman, MD, Daniel A. Scott, MD

Blood (2012) 120 (21): 3212.

https://doi.org/10.1182/blood.V120.21.3212.3212

Published: 2012

Journal Articles

Problems with implementing a Standardised TCD Screening Program: Impact of TCD Instrumentation Variation on STOP Classification

Soundrie Padayachee, Consultant, Clinical, Scientist, Nicholas Thomas, Clinical, Scientist, Andrew Arnold, Clinical, Scientist, Giselle Padmore-Penniston, Research, Nurse, Co-ordinator, Baba Inusa, MD, FRCPCH

Blood (2010) 116 (21): 2663.

https://doi.org/10.1182/blood.V116.21.2663.2663

Published: 2010

Journal Articles

Estimated GFR Derived From Plasma Creatinine by Mass Spectrometry (MSMS) Is A Reliable Measure of Renal Function During the Hyperfiltration Phase In Sickle Cell Disease (SCD)

Baba Inusa, MD, FRCPCH, Caroline Booth, MD, Charles Turner, PhD, Helen Appleby, BSc, Giselle Padmore-Penniston, B.Sc, R. Neil Dalton, PhD

Blood (2010) 116 (21): 2649.

https://doi.org/10.1182/blood.V116.21.2649.2649

Published: 2010

Journal Articles

Long-Term Safety and Efficacy of Deferasirox (Exjade ® ) In Transfused Patients with Sickle Cell Disease Treated for up to 5 Years

Elliott Vichinsky, MD, Francoise Bernaudin, MD, Gian Luca Forni, MD, Renee Gardner, MD, Kathryn Hassell, MD, Matthew M. Heeney, MD, Baba Inusa, MD, Abdullah Kutlar, MD, Peter A. Lane, MD, Liesl Mathias, MD, John B. Porter, MD, Cameron K Tebbi, MD, Felicia L. Wilson, MD, Louis Griffel, MD, Wei Deng, PhD, Vanessa Giannone, BSN, Thomas D. Coates, MD

Blood (2010) 116 (21): 845.

https://doi.org/10.1182/blood.V116.21.845.845

Published: 2010

NARROW

Prevention of Morbidity in Sickle Cell Disease Phase II (Improvement of Cognition in children with Sickle Cell Disease with Auto-adjusting Continuous Positive Airways Pressure: Phase II) (POMS 2b paediatric cohort)

Prevention of Morbidity in Sickle Cell Disease Phase II (Improvement of Pain and Quality of Life in Children with Sickle Cell Disease with Auto-adjusting Continuous Positive Airways Pressure: Phase II) (POMS 2b pediatric cohort)

Overnight Respiratory Support for Prevention of Morbidity in Sickle Cell Disease (POMS 2a) - Parent and Child Preferences

Cerebral Blood Flow-Velocity Is Associated with Increased Leukocyte Count and Systolic Blood Pressure in HbSS but Not HbSC

Prevention of Morbidity in Sickle Cell Disease (POMS 2): A Pilot Study of Nocturnal Respiratory Support Shows That Auto-Adjusting Positive Airways Pressure Is Safe and Is Preferred to Oxygen Therapy

A 2-Dose Schedule of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Given to Children with Sickle Cell Disease Previously Immunized with 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23): Results of a Phase 3 Study

Problems with implementing a Standardised TCD Screening Program: Impact of TCD Instrumentation Variation on STOP Classification

Estimated GFR Derived From Plasma Creatinine by Mass Spectrometry (MSMS) Is A Reliable Measure of Renal Function During the Hyperfiltration Phase In Sickle Cell Disease (SCD)

Long-Term Safety and Efficacy of Deferasirox (Exjade ® ) In Transfused Patients with Sickle Cell Disease Treated for up to 5 Years

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only